Cargando…
Therapeutic silencing of SMOC2 prevents kidney function loss in mouse model of chronic kidney disease
Chronic kidney disease (CKD) is associated with substantial morbidity and mortality. We developed a mouse model that mimics human CKD with inflammation, extracellular matrix deposition, tubulointerstitial fibrosis, increased proteinuria, and associated reduction in glomerular filtration rate over ti...
Autores principales: | Xin, Cuiyan, Lei, Jiahui, Wang, Qian, Yin, Yixia, Yang, Xiaoqian, Moran Guerrero, Jose Alberto, Sabbisetti, Venkata, Sun, Xiaoming, Vaidya, Vishal S., Bonventre, Joseph V. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8524153/ https://www.ncbi.nlm.nih.gov/pubmed/34703992 http://dx.doi.org/10.1016/j.isci.2021.103193 |
Ejemplares similares
-
Meclizine Preconditioning Protects the Kidney Against Ischemia–Reperfusion Injury
por: Kishi, Seiji, et al.
Publicado: (2015) -
Epigenetic silencing of SMOC1 in traditional serrated adenoma and colorectal cancer
por: Aoki, Hironori, et al.
Publicado: (2017) -
The Associations of Plasma Biomarkers of Inflammation With Histopathologic Lesions, Kidney Disease Progression, and Mortality—The Boston Kidney Biopsy Cohort Study
por: Srivastava, Anand, et al.
Publicado: (2021) -
Plasma Kidney Injury Molecule-1 in Systemic Lupus Erythematosus: Discordance Between ELISA and Proximity Extension Assay
por: Schmidt, Insa M., et al.
Publicado: (2022) -
Smoc1 and Smoc2 regulate bone formation as downstream molecules of Runx2
por: Takahata, Yoshifumi, et al.
Publicado: (2021)